Background: The incidence of NAFLD is increasing. Preclinical evidences indicate that modulation of the gut microbiome could be a promising target in nonalcoholic fatty liver disease. Method: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback